Aug 16, 2011
Federal Court Certifies Class Action In Antitrust Lawsuit Over Wellbutrin
A federal judge has certified class action antitrust claims against GlaxoSmithKline, maker of the popular antidepressant drug Wellbutrin XL, for allegedly using sham patent suits to delay generic versions of the drug from making their way to the market.